Michal Shaked, PhD MBA is a researcher and innovation leader with nearly 15 years of experience across academia, clinical diagnostics, and pharma. At Novo Nordisk, she drives early research and target discovery, leveraging novel technologies, multi-omics, and AI to advance translational solutions. With a PhD in molecular biology and an MBA in strategy and entrepreneurship, she brings a unique blend of biological expertise and strategic insight. Michal is passionate about bridging science and innovation to improve patients' lives through interdisciplinary collaboration.